Status:

UNKNOWN

Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Cancer

Lead Sponsor:

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Collaborating Sponsors:

Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

Peking University Cancer Hospital & Institute

Conditions:

Esophageal Neoplasms

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Esophageal cancer is one of the major diseases that seriously threatens an individual's health and life. To reduce the incidence of postoperative complications and mortality of esophageal cancer, thor...

Detailed Description

Esophageal resection remains the mainstay of treatment for esophageal cancer patients. Despite improvements in surgical technique and perioperative management, esophagectomy carries considerable opera...

Eligibility Criteria

Inclusion

  • 18 years≤age≤ 80 years;
  • Histologically diagnosed with squamous cell carcinoma by endoscopic biopsy, cT1-3N0M0;
  • Primary tumour is located in the thoracic oesophagus
  • No clinical evidence of distant organ metastasis
  • No severe comorbidity, can tolerate anesthesia;
  • ECOG PS scores≤2;
  • The patients sign informed consents by themselves.

Exclusion

  • Cervical or abdominal oesophageal carcinoma;
  • Previous oesophagectomy, gastrectomy, or mediastinal surgery;
  • Current uncontrolled illness such as severe cardiac disease, uncontrollable hypertension or diabetes, or active bacterial infection;
  • Unable to tolerate tracheal intubation and general anaesthesia as determined by an anaesthesiologist preoperatively;
  • Pregnant or lactating women;
  • ECOG PS scores\>2;
  • Considered unsuitable, such as those who do not agree to participate in the trial.

Key Trial Info

Start Date :

April 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2022

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT04125849

Start Date

April 1 2020

End Date

December 1 2022

Last Update

April 15 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cancer Hospital of Chinese Academy of Medical Sciences Shenzhen Center

Shenzhen, Guangdong, China, 518000